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Warwick, CovenABSTRACTObjectives: The purpose of this study was to systematically review trial-based economic evaluations of manual
therapy relative to other alternative interventions used for the management of musculoskeletal conditions.
Methods: A comprehensive literature search was undertaken in major medical, health-related, science and health
economic electronic databases.
Results: Twenty-five publications were included (11 trial-based economic evaluations). The studies compared cost-
effectiveness and/or cost-utility of manual therapy interventions to other treatment alternatives in reducing pain (spinal,
shoulder, ankle). Manual therapy techniques (eg, osteopathic spinal manipulation, physiotherapy manipulation and
mobilization techniques, and chiropractic manipulation with or without other treatments) were more cost-effective than
usual general practitioner (GP) care alone or with exercise, spinal stabilization, GP advice, advice to remain active, or brief
pain management for improving low back and shoulder pain/disability. Chiropractic manipulation was found to be less
costly andmore effective than alternative treatment comparedwith either physiotherapy orGP care in improving neck pain.
Conclusions: Preliminary evidence from this review shows some economic advantage of manual therapy relative to
other interventions used for the management of musculoskeletal conditions, indicating that some manual therapy
techniques may be more cost-effective than usual GP care, spinal stabilization, GP advice, advice to remain active, or
brief pain management for improving low back and shoulder pain/disability. However, at present, there is a paucity of
evidence on the cost-effectiveness and/or cost-utility evaluations for manual therapy interventions. Further
improvements in the methodological conduct and reporting quality of economic evaluations of manual therapy are
warranted in order to facilitate adequate evidence-based decisions among policy makers, health care practitioners, and
patients. (J Manipulative Physiol Ther 2014;37:343-362)
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cine context (eg, chiropractic and osteopathy) and consists of
different techniques (eg, manipulation, mobilization, static
stretching, andmuscle energy techniques). The definition and
purpose of manual therapy vary across health care
professionals.
The use of manipulation and mobilization has been
recommended in clinical practice guidelines in the United
States, Great Britain, Canada, and the Netherlands.3–9
Although past research evidence on the clinical effectiveness
10–19 and safety 20–27 of manual therapy relative to other
interventions is abundant, the evidence on cost-effectiveness
is insufficient and inconclusive.28–36 Moreover, to our best
knowledge, a systematic review of full economic evaluations
of recent evidence (ie, cost-effectiveness [CEA] and/or cost-
utility analysis [CUA]) alongside randomized controlled
trials (RCTs) of manual therapy has not been conducted.
In light of limited health care resources, policy makers,
health care providers, and researchers need to make informed
decisions in prioritizing and allocating resources to the
provision of health care interventions that are both effective
and cost saving. Ideally, the decision-making process should
be based on high-quality evidence summarizing incremental
costs and effects of a health care intervention of interest
compared with alternative interventions.
The aim of this review was to systematically identify,
appraise, and evaluate the evidence on trial-based economic
evaluations (cost-effectiveness and/or cost-utility) of manual
therapy relative to other alternative interventions used for the
management of musculoskeletal conditions.
METHODS
This review is part of a large technical report of comparative
benefits and harms of manual therapy interventions for the
management of musculoskeletal and nonmusculoskeletal
conditions, commissioned by the Royal College of Chiroprac-
tors in the United Kingdom (http://www2.warwick.ac.uk/fac/
med/research/hscience/pet/reportforcollegeofchiropractors/).
A comprehensive literature search was undertaken as
part of a wider search for this report. The following medical,
health-related, science and health economic electronic
databases were searched (through August 2011): MED-
LINE (Ovid), Embase, Mantis, Index to Chiropractic
Literature, CINAHL, Cochrane Airways Group trial
register, Cochrane Complementary Medicine Field register,
and Cochrane Rehabilitation Field register (via
CENTRAL), Science Citation Index, AMED, CDSR,
National Health Service (NHS) DARE, NHS HTA, NHS
EED, CENTRAL, ASSIA, and Social Science Citation
Index. The search strategy used in MEDLINE is provided in
Appendix 1. Search terms were restricted to subject heading
and free-text terms related to manual therapy. Broader terms
such as “physiotherapy”were not included because initial tests
suggested that the volume of the literature identified using such
a broad search strategy would not be manageable. To keep thesearch as open as possible, no condition terms were included.
The search was limited to the study types included in the wider
report by the use of recognized search filters, including the
NHS Centre for Reviews and Dissemination NHS EED filter
(see: http://www.crd.york.ac.uk/). This performance of this
filter has been tested.37 No date limits were applied. The search
results were updated on February 15, 2013. Additional studies
were sought through references of relevant primary studies and
systematic reviews.
This review included English-language full-text publica-
tions of RCTs that evaluated the cost-effectiveness and/or
cost-utility of manual therapy (eg, manipulation, mobiliza-
tion, static stretching, chiropractic care, muscle energy
techniques alone or in combination) compared with alterna-
tive interventions (eg, no treatment, placebo, and usual care)
used for the management of musculoskeletal conditions. We
defined musculoskeletal conditions as disorders of muscles,
nerves, tendons, ligaments, joints, cartilage, and spinal disks
that develop over time. They can be categorized as spinal (eg,
mid, low back or neck pain, sciatica, and headaches), upper
extremity (eg, shoulder disorders, carpal tunnel syndrome,
and lateral epicondylitis), and lower extremity (eg, ankle
sprain) disorders.
We excluded studies where manual therapy was used to
treat acute injuries such as fractures and dislocations (eg, to
realign bones), except when used for rehabilitation
purposes. Studies reporting only costs, only outcomes,
reviews, protocols, and conference abstracts were excluded.
Cost-consequence studies were excluded because they
present an array of different outcomes and cost measures.
Studies for which there was insufficient information to
calculate the incremental cost-effectiveness ratios (ICERs)
for CEA or CUA were also excluded.
Two independent reviewers (A.T. and P.S.) screened
all identified bibliographic records for title/abstract and
then for full text. Any disagreements were resolved
through consensus or by recourse to a third-party reviewer
(A.C.). The first author independently extracted relevant
data from included studies which was checked by another
reviewer (P.S). The extracted data included study
characteristics (eg, author name, country, year of publi-
cation, sample size, and follow-up duration), types of
participants (eg, condition, age, and sex), types of
interventions/comparators, type of economic analysis
(cost-effectiveness, cost-utility), perspective (societal,
health care system, individual), study currency, discount-
ing, and information pertinent to risk of bias (ROB)/study
quality assessment items. The outcomes included pain/
disability scores, quality of life (QOL) measures, quality-
adjusted life-years (QALYs), costs, and ICERs. We
converted mean costs to UK £2012 prices using
country-specific gross domestic product deflators38 and
Purchasing Power Parities from Organisation for Eco-
nomic Co-operation and Development (£1 = US $1.45 in
2012 prices).39 We calculated ICERs for each study, if not
345Tsertsvadze et alJournal of Manipulative and Physiological Therapeutics
Cost-Effectiveness of Manual TherapyVolume 37, Number 6reported directly. We chose a single willingness to pay
(WTP) threshold of £20000 to £30000, which is currently
used for the National Institute for Health and Care
Excellence (NICE).
The methodological and reporting quality of economic
analyses of the included studies were assessed using the
Drummond 10-item checklist.40 This tool helps to assess
the following domains: (a) adequacy of research question,
(b) description of treatments, (c) identification of costs
and consequences, (d) measurement of costs and conse-
quences, (e) valuation and adjustment of costs and
consequences for different timing, ( f ) incremental
analysis of costs and consequences of alternative treat-
ments, (g) uncertainty in the estimates of costs and
consequences, and (g) presentation and discussion of
study results and issues of concern.
The ROB in relation to clinical outcomes (ie, pain
and health-related QOL measures) was assessed using the
11-item checklist of internal validity criteria recommend-
ed by the Cochrane Back Review Group.41 This tool is
designed to assess the following domains of bias per each
outcome: (a) selection bias (ie, methods of randomization
and allocation concealment, similarity of groups in
important prognostic factors at baseline), (b) performance
bias (ie, blinding of patients and care providers, similarity
of cointerventions across study groups), detection bias
(ie, blinding of outcome assessors), and attrition bias
(ie, noncompliance, dropouts, and intention-to-treat
analysis). Based on the number of satisfied criteria
(response: yes), the studies were assigned a low (at least
6 criteria satisfied) or a high (5 or fewer criteria satisfied)
ROB. This threshold was selected given the empirical
evidence showing that trials satisfying at least 6 criteria
reported smaller effect sizes than trials satisfying fewer
criteria (5 or less).42 In support of this construct, the
previous research has demonstrated that studies of low
methodological quality (ie, higher ROB) tend to exagger-
ate the treatment effects.43,44
The results were organized by condition and, within each
condition, by type of manual therapy. The results were
summarized in text and tables.RESULTS
We initially identified 25539 (16976 after de-duplication)
bibliographic records, of which 1014 were included in the
technical report through the 2-stage screening process
(abstract/title and full text). The updated search contributed
additional 229 potentially relevant records. Thus, a total of
1243 records were screened for the cost-effectiveness review,
of which 129 passed at title/abstract screening level and were
judged to be potentially relevant for full-text review.
One hundred four of the 129 publications were excluded at
full text (these included studies that reported information oncosts [n = 31] or outcomes [n = 3] only, cost-consequence
studies [n = 9], and CUAs where not enough information was
provided to calculate the ICER [n = 2]). Figure 1 provides full
details of the search results and reasons for exclusion. The
remaining 25 publications, representing 11 unique
RCTs included in the review, were the following: Bosmans
et al,45–47 Williams et al,48,49 the UKBack Pain Exercise and
Manipulation (BEAM) trial team 2004,50–52 Niemisto
et al,53,54 Rivero-Arias et al,55,56 Bergman et al,57–60
Whitehurst et al,61,62 Korthals-de Bos et al,63,64 Lewis
et al,65,66 Lin et al,67,68 and Critchley et al.69
The study, participant, treatment, methodology, and
outcome characteristics for the 11 included trials are presented
in Table 1. The studies were conducted in the United
Kingdom,48,50,55,61,65,69 the Netherlands,45,57,63 Finland,53
and Australia.67 The sample size ranged from 94 67 to 1334
participants.50 Duration of follow-up ranged from 6 48,57,65,67
to 24 months.53 The mean age of participants ranged from
3753 to 51 years.65 The participants presented with spinal
pain (low/upper back, neck),48 low back pain,50,53,55,61,69
neck pain,45,63,65 shoulder pain,57 and ankle fractures.67
Most studies included participants with nonspecific pain
(ie, patients with spinal/shoulder pathology, rheumatoid
arthritis, malignancies, pregnancy, osteoarthritis, psychi-
atric disease, or herniated disk were excluded). In the
reviewed studies, interventions whose main components
included manual therapy techniques (eg, manipulation and
mobilization) were compared with usual general practitioner
(GP) care,48,50,57,63 GP advice,53 physiotherapist advice,55
pain management program (back pain education, strengthen-
ing, stretching, aerobic exercise),61,69 exercise,45 physiother-
apy (postural relaxation, walking exercises),63,67 or advice
and exercise (A&E).65 Most interventions lasted from 6 to
12 weeks. The cost-effectiveness analyses were based on
pain intensity and disability measures. The utility for QALY
was based on the EuroQoL EQ-5D (European Quality of
Life–5 Dimensions) or the Assessment of Quality of Life
(AQoL). The perspective of economic evaluations was
societal 45,53,55,57,63,65 or health care system.48,50,55,61,65,67,69
All studies from a societal perspective included direct
medical, direct nonmedical, and indirect costs. Given
12 months of follow-up in most studies, no discounting
was undertaken (see Table 1).Methodological and Reporting Quality of Economic Evaluations
The quality assessment showing the percentage of
items with “yes” on the Drummond checklist is presented
in Table 2. In all studies, the research question was
clearly formulated, with good descriptions of the
interventions and comparators. Most studies reported all
important costs (ie, direct medical, direct nonmedical, and
indirect) and consequences (ie, outcome measures).
Because costs were not individually itemized for more
than half of the studies, it was not clear what data were
Total # of identified records
(n = 1,243)
Potentially relevant records
n = 129
Not relevant
n = 1,114
Included in the review
n = 25 relevant records (11 unique studies)
Not relevant (n=104)
Costs only (n=31)
Outcomes only (n=3) 
Cost-consequence studies (n=9)
Cost-utility analyses (not enough information to
calculate ICERs) (n=2)
Not economic evaluations (n=2)
Duplicate (n=4)
Systematic and other reviews (n=23)
Not relevant intervention (n=11)
Abstract/dissertation/commentary (n=12)
Study protocols (n=6)
Non randomized study (n=1)
Abstract/title level
General inclusion/exclusion criteria
Full text level
Databases
MEDLINE, Embase, CENTRAL, Mantis,
Index to Chiropractic Literature, CINAHL, 
Cochrane Complementary Medicine Field 
register, AMED, CDSR, NHS DARE, NHS 
HTA, NHS EED, ASSIA, and Social
Science Citation Index
Hand search
References of relevant systematic
reviews
Fig 1. Flowchart of the study selection process.
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valuation methods of costs and consequences, which were
judged as adequate. The ICERs were reported in all
studies, except for 1 study where information was
provided to calculate this ratio.67,68 The studies provided
detailed discussion sections by highlighting main study
findings, interpretation of the findings, study strengths
and limitations, consistency of findings with other
studies, and future directions.Risk of Bias Assessment
Risk of bias assessments are presented in Table 3.
Briefly, 7 of the 11 included trials were rated as having low
ROB 45,50,53,57,61,67,69 and 4 trials as having highROB.48,55,63,65 Patients and care providers in the studies
were not blinded to the intervention type, and because the
outcomes were self-reported (eg, pain, QOL), blinding of
assessors was considered not applicable. Most of the studies
reported adequate methods of randomization and treatment
allocation concealment. Results of all studies were based on
intention-to-treat analysis.Cost-Effectiveness and/or Cost-Utility of Manual Therapy
Results are presented by condition in the text below as
well as in Table 4.
Spinal Pain (Low Back, Upper Back, and/or Neck). In a trial by
Williams et al48,49 the addition of osteopathic manipu-
lation to usual GP care was more costly compared with
Table 1. Included RCTs and Their Characteristics
Study ID
Study Participants
Eligibility Criteria
Study Perspective Type of
Costs Methods Interventions (Components)
Outcome Measures
Follow-up
Spinal (upper/low back, neck, or both) pain
Williams
2004 48,49
UK
Sample size: 201 patients
(randomised), 136 patients
(analysed)
Age (mean): NR
Male (%): NR
Inclusion: patients aged
16-65 years with non-
specific neck or back pain
for 2-12 weeks
Exclusion: patients with
serious spinal pathology,
nerve root pain, previous
spinal surgery, or major
psychological disorder
Perspective: National
Health Service
Direct medical costs: GP
and outpatient consultations,
investigations, prescribing,
hospital stay
Direct non-medical costs: NA
Indirect costs: NA
Discounting: None
(study duration b 1 year)
Intervention 1: OSM
(osteopathic manipulation +
advice on keeping active,
exercise regularly, and
avoiding excessive rest) +
Usual GP care [3-4 sessions]
Intervention 2: Usual
GP care
[3-4 sessions]
Duration: 2 months
Mean QALY (based on
quality of life score
EuroQoL EQ-5D)
ICER
Last follow-up: 6 months
Low Back Pain
Critchley
2007 69
UK
Sample size: 212 patients
(randomised), 148 patients
(analysed)
Age (mean): 44 years
Male (%): 50
Inclusion: patients aged
≥18 years referred by GP
with non-specific LBP
N12 weeks
Exclusion: previous spinal
surgery, PT for LBP within
6 months prior to enrolment,
chronic conditions such as
rheumatoid arthritis or
disabilities rendering
unsuitable for the treatment
Perspective: National
Health Service
Direct medical costs:
Hospital stays and visits,
staff time, procedures,
investigations
Direct non-medical costs: NA
Indirect costs: NA
Discounting: 3.5%
Intervention 1: Individual
PT (joint manipulation,
mobilisation, massage, back
care advice, individual
exercises including trunk
muscle retraining, stretches,
and general spinal mobility)
[12 sessions]
Intervention 2: spinal
stabilisation PT (transverses
abdominis and lumbar
multifidus muscle training,
exercise for spinal stability)
[8 sessions]
Intervention 3: Pain
management (back pain
education, strengthening,
stretching, aerobic exercise,
cognitive behavioural
approach) [8 sessions]
Duration: NR
Mean QALY (based on
quality of life score
EuroQoL EQ-5D)
ICER
Last follow-up:
18 months
Niemisto
2005 53,54
Finland
Sample size: 204 patients
(randomised), 138 patients
(analysed)
Age (mean): 37 years
Male (%): 46
Inclusion: patients
24-46 years of age with
non-specific LBP
≥ 3 months and disability
measured with ODI of 16%
Exclusion: malignancies,
ankylosing spondylitis,
severe osteoporosis,
osteoarthritis, paralysis,
progressive neurologic
disorder, haemophilia,
spinal infection, spinal
operation, vertebral fracture
within 6 months of trial,
pregnancy, severe sciatica,
and psychiatric disease
Perspective: Societal
Direct medical costs:
Physician visits,
physiotherapy visits,
outpatient clinics, hospital
stays, x-rays
Direct non-medical costs:
Drug and travel costs
Indirect costs:
Productivity loss costs
Discounting: None
Intervention 1:
Manipulative combination
treatment (manipulation
with muscle energy
technique to correct any
biomechanical dysfunction
in the lumbar or pelvic
segments, stabilizing
exercise to correct the
lumbopelvic rhythm,
GP advice)
[4 sessions]
Intervention 2: GP advice
(booklet, advice on exercise,
muscle stretch, and stability)
[1 session]
Duration: 4 weeks
ICER (based on pain and
ODI scores)
Last follow-up:
24 months
(continued on next page)
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Table 1. (continued)
Study ID
Study Participants
Eligibility Criteria
Study Perspective Type of
Costs Methods Interventions (Components)
Outcome Measures
Follow-up
Rivero-Arias
2006 55,56
UK
Sample size: 286 patients
(randomised and analysed)
Age (mean): 41 years
Male (%): 47.5
Inclusion: patients
≥18 years with LBP
≥ 6 weeks
Exclusion: patients with
systemic rheumatologic
disease, gynaecological
problems, ankylosing
spondylitis, tumours,
infections, past spinal
surgery, or treatment for
physical problems
Perspective: National
Health Service and Societal
Direct medical costs: NHS
costs (intervention, GP
visits, hospitalisations,
prescribed items)
Direct non-medical costs:
Health care purchased by
patient (private
consultations with
osteopaths, chiropractors,
over the counter drugs)
Indirect costs: employment
costs (number of days off work)
Discounting: None
(12 months follow-up)
Intervention 1: PT (joint
manipulation, mobilisation,
massage, stretching, spinal
mobility and strengthening
exercise, heat/cold therapy)
+ advice to remain active
(back book) [5 sessions]
Intervention 2: Advice to
remain active (back book)
[1 session]
Duration: NR
Mean QALY
(based on
quality of life score
EuroQoL EQ-5D)
ICER
Last follow-up:
12 months
UK BEAM
2004 50–52
UK
Sample size: 1334 patients
(randomised), 1287 patients
(analysed)
Age (mean): 43.1 years
Male (%): 44
Inclusion: patients
18-65 years of age with
non-specific LBP
≥ 1 months and RMDQ ≥ 4
Exclusion: patients with
malignancies, ankylosing
spondylitis, osteoporosis,
infections, past spinal
surgery, psychiatric disease,
treatment for physical
problems 3 months before
trial, chronic use of steroids,
cardiovascular condition,
or previous attendance to
pain management clinic
Perspective: National
Health Service
Direct medical costs: GP
care/consultations, visits,
outpatient attendance,
hospital stay, programmes
of exercise, manipulation
Direct non-medical costs: NA
Indirect costs: NA
Discounting: None
(12 months follow-up)
Intervention 1: GP care
Intervention 2: Exercise +
GP care [9 sessions]
Intervention 3:
Manipulation (a
multidisciplinary group
developed a package of
techniques representative of
those used by the UK
chiropractic, osteopathic,
and physiotherapy
professions) + GP care
[9 sessions]
Intervention 4:
Manipulation + exercise +
GP care [9 sessions]
Duration: 12 weeks
Mean QALY
(based on
quality of life score
EuroQoL EQ-5D)
ICER
Last follow-up:
12 months
Whitehurst
2007 61,62
UK
Sample size: 402 patients
(randomised and analysed)
Age (mean): 41 years
Male (%): 47
Inclusion: patients
18-64 years of age with
non-specific LBP b 12 weeks
Exclusion: serious spinal or
systemic disorders, long-
term sick leave
(N 12 weeks), osteoporosis,
inflammatory arthritis,
steroid treatment
(N 12 weeks), pregnancy,
previous hip/back surgery or
fracture, abdominal surgery,
back pain treatment by
another professional
Perspective: National
Health Service
Direct medical costs:
|treatment sessions
(PT and |BPM), outpatient
attendance, inpatient
attendance, primary care
contacts, other health
professionals (e.g.,
acupuncture, chiropractic,
osteopathy, physiotherapy)
Direct non-medical costs: NA
Indirect costs: NA
Discounting: None
(12 months follow-up)
Intervention 1: Manual PT
(articulatory mobilisation,
manipulation, or soft tissue
techniques, spinal
stabilisation, back exercise,
ergonomic advice, back
education) [7 sessions]
Intervention 2: BPM
(general fitness, exercise for
spinal mobility, explanation
about pain mechanisms,
distress, coping strategies)
[2-day course plus
clinical tutoring]
Duration: NR
Mean QALY
ICER (based on
EuroQoL
EQ-5D; RMDQ
score)
Last follow-up:
12 months
Neck Pain
Bosmans 2011 45–47
The Netherlands
Sample size: 146 patients
(randomised and analysed)
Age (mean): 45 years
Male (%): 40
Perspective: Societal
Direct medical costs:
Primary care (GP, SMT,
BGA, massage,
Intervention 1: SMT
(manipulation using passive
movement of a joint beyond
its active and passive limit
Mean QALY
ICER (based on mean
QALY; pain; perceived
recovery; NDI)
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Table 1. (continued)
Study ID
Study Participants
Eligibility Criteria
Study Perspective Type of
Costs Methods Interventions (Components)
Outcome Measures
Follow-up
Inclusion: patients
18-70 years of age with
non-specific neck pain
(4-12 weeks)
Exclusion: malignancy,
neurologic disease,
herniated disc, or systemic
rheumatic disease
homeopathy, outpatient
visit, x-ray, tomography,
MRI), supportive care
Direct non-medical costs:
Informal care, paid home help
Indirect costs: Absenteeism
from paid/unpaid work
Discounting: None
(12 months follow-up)
of motion with a localized
thrust of small amplitude to
regain motion, restore
function, and reduce pain;
mobilisation using skilled
low grade passive movement
with large amplitude to
restore movement and
relieve pain) [6 sessions]
Intervention 2: BGA
(gradually increasing
exercise program)
[18 sessions]
Duration: 6 weeks
Last follow-up:
12 months
Korthals-de
Bos 2003 63,64
The Netherlands
Sample size: 183 patients
(randomised), 178 patients
(analysed)
Age (mean): 45 years
Male (%): 40
Inclusion: patients
18-70 years of age with
non-specific neck pain
(≥ 2 weeks)
Exclusion: previous neck
surgery, malignancy,
neurologic disease, fracture,
herniated disc, or systemic
rheumatic disease
Perspective: Societal
Direct medical costs: GP,
SMT, PT, outpatient
appointments,
hospitalisation, exercise,
home care
Direct non-medical costs:
Alternative therapy, home
care, friend’s or partner’s
help, travel
Indirect costs: Absenteeism
from paid/unpaid work
Discounting: None (trial
duration: 12 months)
Intervention 1: SMT
(combination of techniques
described by Cyeariax,
Kaltenborn, Maitland, and
Mennel using hands-on
muscular and articular
mobilisation techniques,
coordination or stabilisation
techniques, and joint
mobilisation with low-
velocity passive
movements) [6 sessions]
Intervention 2: PT (active,
postural, or relaxation
exercises, stretching,
massage, manual traction)
[12 sessions]
Intervention 3: GP care
(standard care, advice on
self-care, education,
ergonomic issues,
paracetamol or NSAIDs, if
necessary) [1 session and
optional biweekly follow-up
visits]
Duration: 6 weeks
Mean QALY
ICER (based on EuroQoL
EQ-5D; pain; NDI)
Last follow-up:
12 months
Lewis 2007 65,66
UK
Sample size: 350 patients
(randomised), 346 patients
(analysed)
Age (mean): 51 years
Male (%): 37
Inclusion: patients
≥ 18 years with non-
specific neck pain who
consulted only primary care
team in the previous
6 months
Exclusion: weight loss,
fever, progressive
neurologic signs, muscle
weakness, sensation
disturbance, malignancy,
systemic rheumatic disease,
osteoporosis,
contraindications to the
Perspective: National
Health Service and Societal
Direct medical costs: Study
intervention sessions, GP
consultations, outpatient
attendance (e.g.,
rheumatology,
physiotherapist, neurologist,
emergency, radiographer,
acupuncturist)
Direct non-medical costs:
patient expenses (e.g.,
prescription drugs, over-the-
counter medicines, devices)
Indirect costs: Absenteeism
from paid work
Discounting: None (trial
duration: 6 months
Intervention 1: A & E
[8 sessions]
Intervention 2: A & E +
SMT (passive/active
assisted hands-on
movements, joint and soft
tissue mobilisations or
manipulations graded as
appropriate to the patient’s
signs and symptoms)
[8 sessions]
Intervention 3: A & E +
PSWD [8 sessions]
Duration: 6 weeks
Mean QALY
ICER (based on EuroQoL
EQ-5D; NPQ)
Last follow-up: 6 months
(continued on next page)
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Table 1. (continued)
Study ID
Study Participants
Eligibility Criteria
Study Perspective Type of
Costs Methods Interventions (Components)
Outcome Measures
Follow-up
study treatments,
taking anticoagulants
Shoulder Pain
Bergman 2010 57–60
The Netherlands
Sample size: 150 patients
(randomised), 140 patients
(analysed; excluding
2 outliers)
Age (mean): 48 years
Male (%): 49
Inclusion: patients ≥ 18
years with non-specific
shoulder pain without
shoulder treatment in
the past 3 months
Exclusion: fractures,
ruptures or dislocations in
the shoulder region,
previous orthopaedic
surgery, contraindications
for manipulative therapy,
cervical nerve root
compression, rheumatic
disorder, dementia,
psychiatric disorder, or
abdominal pathology
Perspective: Societal
Direct medical costs:
treatment by GP,
physiotherapist, manual,
occupational, exercise or
complementary health
therapists, visits to
consultant in orthopedic
surgery, acupuncturist,
neurology, rheumatology,
rehabilitation medicine, and
hospitalisation
Direct non-medical costs:
out-of-pocket expenses,
costs for paid/unpaid help
Indirect costs: loss of
production due to sick leave
from paid/unpaid work
Discounting: None
(trial duration: 6 months)
Intervention 1: SMT (high
velocity low amplitude
manipulation and passive
low velocity mobilisation
within the range of joint
motion) [6 sessions]
+ Usual GP care (advice on
daily living, if needed
analgesics, NSAIDs,
corticosteroid injections, or
PT including massage and
exercise)
Intervention 2: Usual GP
care [number sessions: NR]
Duration: 12 weeks
ICER (based on perceived
recovery; shoulder pain;
shoulder disability;
general health)
Last follow-up: 6 months
Ankle Fracture
Lin 2008 67,68
Australia
Sample size: 94 patients
(randomised), 92 patients
(analysed)
Age (mean): 41.5 years
Male (%): 54
Inclusion: patients
≥ 18 years with ankle
fractures treated with cast
immobilisation with cast
removed the week before
the trial entry, pain VAS
≥ 2, approved to weight-
bear as tolerated or partial
weight-bear
Exclusion: patients with
significant pathologies
Perspective: Health care
system and patient
Direct medical costs:
outpatient physiotherapy,
medical specialists, GP,
emergency department,
hospitalisation, medication,
investigations, private
health providers,
Direct non-medical costs:
public transport, private
vehicle
Indirect costs: None
Discounting: None
(trial duration: 6 months)
Intervention 1: MT (large
amplitude oscillatory
anterior-posterior glides of
the talus) + PT (exercise,
gait retraining, walking aids,
advice, ice, elevation and
progression if required)
[8 sessions]
Intervention 2: PT
[5 sessions]
Duration: 4 weeks
ICER (quality of life
AQol: QALY)
Last follow-up: 6 months
A&E, advice and exercise; BGA, behavioral graded activity; BPM, brief pain management; EQ-5D, European Quality of Life-5 Dimensions; GP, genera
practitioner; ICER, incremental cost-effectiveness ratio; LBP, lower back pain; MRI, magnetic resonance imaging; MT, manual therapy; NA, no
applicable; NDI, Neck Disability Index; NHS, National Health Service; NPQ, Northwick Park Neck Pain Questionnaire; NR, not reported
NS, statistically nonsignificant; NSAIDs, nonsteroidal anti-inflammatory drugs; ODI, Oswestry Disability Index; OSM, osteopathic manual therapy
PSWD, pulsed shortwave diathermy; PT, physiotherapy/physical therapy; QALY, quality-adjusted life year; RMDQ, Roland-Morris Disability
Questionnaire; SMT, spinal manual therapy.
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£4674 per QALY gained. This estimate was lower than
the threshold of £30 000 used by the NICE, suggesting
the addition of osteopathic manipulation to usual GP care
as a potentially cost-effective option for patients with
spinal pain.l
t
;
;Low Back Pain. In the study by Critchley et al,69 pain
management dominated both individual physiotherapy and
spinal stabilization physiotherapy. Individual physiotherapy
was more effective and marginally more costly than spinal
stabilization physiotherapy, with a mean ICER of £1279 per
QALY gained.
Table 2. Methodological Quality of Economic Evaluations in the Included Studies (the Drummond Checklist for Critical Appraisal of
Economical Evaluation)40
Item no. a
Bergman
et al57–60
Bosmans
et al45–47
Critchley
et al69
Korthals-de
Bos et al63,64
Lewis
et al65,66
Lin
et al67,68
Niemisto
et al53,54
Rivero-Arias
et al55,56
UK
BEAM50–52
Whitehurst
et al61,62
Williams
et al48,49
Item 1 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Item 2 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Item 3 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Item 4 Yes Yes Can't tell (costs) Yes No (costs) Yes Yes Yes Yes Yes Yes
Item 5 Can't tell
(costs)
Yes Can't tell
(costs)
Can't tell
(costs)
Can't tell
(costs)
Can't tell
(costs)
Can't tell
(costs)
Yes Yes Yes Yes
Item 6 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Item 7 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Item 8 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes
Item 9 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes
Item 10 Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes
% of items with “yes” on Drummond checklist
90 100 80 80 80 70 90 100 100 100 100
Item 1:Was a well-defined question posed in answerable form? Item 2: Was a comprehensive description of the competing alternatives given? Item 3: Was
the effectiveness of the programmes or services established? Item 4: Were all the important and relevant costs and consequences for each alternative
identified? Item 5: Were costs and consequences measured accurately in appropriate physical units (e.g. number of physician visits, lost work-days, gained
life-years)? Item 6: Were costs and consequences valued credibly? Item 7: Were costs and consequences adjusted for differential timing? Item 8: Was an
incremental analysis of costs and consequences of alternatives performed? Item 9: Was allowance made for uncertainty in the estimates of costs and
consequences? Item 10: Did the presentation and discussion of study results include all issues of concern to users?
a Responses to items: yes, no, can't tell.
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effectiveness of combination of manual therapy, stabiliza-
tion exercise, and physician consultation compared with
physician consultation alone in patients with low back pain.
This study demonstrated significantly reduced pain inten-
sity for the combination treatment compared with physician
consultation alone at 24-month follow-up (visual analog
scale [VAS] score: 30.7 vs 33.1, P = .01). The associated
ICER was £165 per score improvement on VAS and was
£384 per score improvement on disability scale.
The trial by Rivero-Arias et al55,56 compared physio-
therapy with physiotherapist advice in participants with low
back pain. At 12 months of follow-up, physiotherapy was
more expensive (£320 vs £247) and more effective (QALYs
gained: 0.74 vs 0.69) than the physiotherapist advice group,
but neither the incremental mean costs nor the incremental
mean QALYs between the 2 treatment groups was
statistically significant. The cost per QALY gained was
£1454. If the decision maker is willing to pay £5000, the
probability of physiotherapy being more cost-effective than
physiotherapist advice was 60%.
The UK BEAM50–52 assessed the cost-utility of adding
manipulation, or exercise, or manipulation followed by
exercise to GP care in patients with low back pain. For
12 months, all 3 groups of exercise (£631), manipulation
(£702), and manipulation plus exercise (£612) incurred
higher mean total costs compared with GP care (£449). The
mean number of QALYs gained was also greater for the 3
groups (0.635, 0.659, and 0.651, respectively) comparedwith
GP care (0.618). The ICERs for adding manipulation alone,
exercise alone, or manipulation plus exercise to GP care
relative to GP care alone were £6175, £10692, and £4918,respectively. The combination of manipulation and exercise
dominated exercise alone because of lower costs and better
outcomes in terms of the number of QALYs gained. The
findings of this study also indicated that for additional £91,
manipulation alone could gain an extra 0.008 QALYs
compared with manipulation plus exercise (ICER of
£11360). If the decision maker was willing to pay £10000,
the most cost-effective treatment option for patients with low
back pain was the addition of manipulation to GP care.
Whitehurst et al61,62 compared manual physiotherapy
with a brief pain management program in patients with
acute low back pain. At 12 months of follow-up, the mean
cost per patient for the manual physiotherapy was greater
compared with brief pain management, with a mean
difference of £66. Although the gains in disability
(Roland-Morris Disability Questionnaire [RMDQ] mean
score, 0.33) and utility (mean QALYs, 0.022) were in favor
of manual physiotherapy vs brief pain management, these
differences were not statistically significant. The ICER for
manual physiotherapy relative to brief pain management
was £3006 per QALY gained. If the NHS were willing to
pay £10000 per QALY gained, there was 83% chance that
manual physiotherapy was more cost-effective compared
with brief pain management.Neck Pain. In 1 trial,45–47 Bosmans et al evaluated the
cost-effectiveness of behavioral graded activity program
relative to manual therapy in patients with neck pain.
Compared with manual therapy, treatment with behavioral
graded activity was associated with a statistically significant
reduction in pain intensity (mean VAS score, 0.88) and
disability (mean Neck Disability Index score, 2.40).
Behavioral graded activity was shown to be more cost-
Table 3. Risk of Bias Assessment of the Included RCTs (Adapted From van Tulder et al41)
ROB Item
Bergman
et al57–60
Bosmans
et al45–47
Critchley
et al69
Korthals-de Bos
et al63,64
Lewis
et al65,66
Lin
et al67,68
Niemisto
et al53,54
Rivero-Arias
et al55,56
UK
BEAM
50–52
Whitehurst
et al61,62
Williams
et al48,49
Was the method of
randomization
adequate?
Don't
know
Yes Yes Yes Yes Yes Don't
know
Yes Yes Yes Yes
Was the treatment
allocation
concealed?
Yes Yes Yes Yes Don't
know
Yes Yes Yes Yes Yes Don't
know
Were the groups
similar at baseline
regarding the most
important prognostic
indicators?
Yes Yes Yes No No Yes No No Yes Yes Yes
Was the patient blinded
to the intervention?
No No No No No No No No No No No
Was the care provider
blinded to the
intervention?
Don't
know
Don't
know
No No No No No No No No Don't
know
Was the outcome
assessor blinded to
the intervention?
NA NA NA NA NA NA NA NA NA NA NA
Were cointerventions
avoided or similar?
Don't
know
Don't
know
Yes No No Don't
know
Yes No Don't
know
No Don't
know
Was the compliance
acceptable in all
groups?
Yes No Don't
know
No Yes Yes Yes Yes Don't
know
No Don't
know
Was the dropout rate
described and
acceptable?
Yes Yes No Yes Yes Yes Yes No Yes Yes No
Was the timing of the
outcome assessment
in all groups similar?
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Did the analysis
include an intention-
to-treat analysis?
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Summary ROB Low
ROB
Low
ROB
Low
ROB
High ROB High
ROB
Low
ROB
Low
ROB
High ROB Low
ROB
Low ROB High
ROB
Yes, if item is satisfied; no, if item is not satisfied; Don't know, unclear if item was satisfied or not; Low ROB, if 6 or more items are satisfied (rated as
“yes”); High ROB, if 5 or fewer items are satisfied (rated as “yes”).
NA, not applicable; ROB, risk of bias.
352 Journal of Manipulative and Physiological TherapeuticsTsertsvadze et al
July/August 2014Cost-Effectiveness of Manual Therapyeffective than manual therapy in reducing pain intensity
(ICER: £388 per improvement in pain score) and disability
(ICER: £152 per improvement in disability score) but not
for perceived recovery (ICER: £17444 per improvement in
recovery score).
One trial by Korthals-de Bos et al63,64 evaluated
manual therapy, physiotherapy, and GP care in patients
with neck pain. After 1 year of follow-up, manual
therapy was significantly less costly than physiotherapy
(−£1149) and GP care (−£1260). Moreover, manual
therapy was significantly more effective in reducing neck
pain than physiotherapy (mean difference, 1.20), but not
disability (mean difference, 0.90). The mean differences
in pain intensity (0.10) and disability (−1.40) between
manual therapy and GP care were not statisticallysignificant. The manual therapy demonstrated dominance
(both less costly and more effective) over both
physiotherapy and GP care for perceived recovery and
utility. Also, manual therapy was dominant over
physiotherapy for pain intensity. Physiotherapy and GP
care did not differ in either costs or in improving neck
pain or disability.
Lewis et al65,66 conducted an economic evaluation in
which A&E plus manual therapy or pulsed shortwave
diathermy was compared with A&E alone in patients with
neck pain. At 6 months, the differences in costs, disability,
and QALYs gained between the treatment groups were not
statistically significant. In terms of societal perspective, for
disability, the A&E plus manual therapy had a higher
probability of being cost-effective (up to 55%) than A&E
Table 4. Cost-Effectiveness/Cost-Utility of Manual Therapy Interventions According to Condition – RCTs
Study ID Analysis Health Outcomes
Mean Costs
Mean (SD) Health Effects
Difference in Costs
Incremental Ratio
Spinal (upper/low back, neck, or both) pain
Williams
2004 48,49
UK a
Analysis: CUA
Statistical analysis:
Non-parametric bootstrap
(1000 simulations)
EuroQoL EQ-5D OSM + Usual GP care
Costs: £402
Health effects
EQ-5D: 0.717 (0.248)
QALY: 0.056 (0.101)
Usual GP care
Costs: £286
Health effects
EQ-5D: 0.656 (0.289)
QALY: 0.031 (0.105)
Incremental Costs:
£117
Cost per QALY gained:
£4674
Low Back Pain
Critchley
2007 69
UK b
Analysis: CUA
Statistical analysis:
ANOVA, non-parametric
bootstrap (number of
simulations: NR)
EuroQoL EQ-5D Individual PT
Costs: £574
Health effects
EQ-5D: 0.67
QALY: 0.990
Spinal stabilisation PT
Costs: £459
Health effects
EQ-5D: 0.63
QALY: 0.900
Pain management
Costs: £200
Health effects
EQ-5D: 0.68
QALY: 1.000
Individual PT – spinal
stabilisation
Incremental Costs:
£115
Cost per QALY gained:
£1279
Cost per QALY gained:
Pain management
dominant over both
treatments (individual PT
and spinal stabilisation)
Niemisto
2005 53,54
Finland b
Analysis: CEA
Statistical analysis:
Repeated measures
ANOVA, Intention to
Treat analysis, bootstrap
technique (5000
simulations)
Pain (visual analogue
score), Oswestry Disability
Index (ODI), 15-D
(HRQoL)
MT + exercise +
GP advice
Costs: £4568
Health effects: NR
GP advice
Costs: £5643
Health effects: NR
Incremental Costs:
-£1075
Cost per unit of outcome
improved in:
Pain (VAS)
£165
Disability (ODI)
£384
Rivero-Arias
2006 55,56
UK a
Analysis: CUA
Statistical analysis: Mean
differences and 95% CI
using independent sample t
test (for costs) and
ANCOVA (for QALYs),
multiple imputation for
missing values using linear
regression technique
EuroQoL EQ-5D PT
Costs: £320
Health effects
EQ-5D: 0.73 (0.25)
QALY: 0.740 (0.18)
Physiotherapist advice
Costs: £247
Health effects
EQ-5D: 0.72 (0.26)
QALY: 0.690 (0.23)
Incremental Costs:
£73
Cost per QALY gained:
£1454
UK BEAM
2004 50–52
UK b
Analysis: CUA
Statistical analysis:
Bayesian Markov Chain
Monte Carlo multilevel
analysis
EuroQoL EQ-5D GP (Best) care +
manipulation
Costs: £702
Health effects
QALY 0.659
GP (Best) care +
manipulation + exercise
Costs: £612
Health effects
QALY: 0.651
GP (Best) care + exercise
Costs: £631
GP (Best) care +
manipulation - GP
(Best) care
Incremental costs:
£253
Cost per QALY gained:
£6175
GP (Best) care +
manipulation + exercise
- GP (Best) care
Incremental costs:
£162
(continued on next page)
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Table 4. (continued)
Study ID Analysis Health Outcomes
Mean Costs
Mean (SD) Health Effects
Difference in Costs
Incremental Ratio
Health effects
QALY: 0.635
GP (Best) care
Costs: £449
Health effects
QALY: 0.618
Cost per QALY gained:
£4918
Dominant over GP (Best)
care + exercise
GP (Best) care +
exercise - GP (Best) care
Incremental costs:
£182
Cost per QALY gained:
£10692
Whitehurst 2007 61,62
UK b
Analysis: CUA, CEA
Statistical analysis:
Intention to Treat analysis,
multiple imputation based
on multiple linear regression
models, 95% CIs based on
parametric tests if normal
distribution, and if skewed,
bootstrapping technique
(5000 simulations)
Disability (RMDQ score),
EuroQoL EQ-5D
Manual PT
Costs: £246
Health effects
Mean change disability
(RMDQ): 8.887
QALY: 0.777
BPM
Costs: £180
Health effects
Mean change disability
(RMDQ): 8.553
QALY: 0.755
Incremental costs:
-£66
Cost per RMDQ change:
£198
Cost per QALY gained:
£3006
Neck Pain
Bosmans 2011 45–47
Netherlands b
Analysis: CEA
Statistical analysis:
Intention to Treat analysis,
multiple imputation, CIs
based on bootstrapping
(5000 simulations)
Pain (VAS), disability
(NDI), perceived recovery,
and quality of life (SF-12)
SMT (MOB + MAN)
Costs: £823
Health effects
Mean change
VAS: -3.5 (SE 0.31)
NDI: -8.3 (SE 0.77)
Recovery: 0.76 (SE 0.05)
QALY: 0.770 (SE 0.01)
BGA (increasing exercise
program)
Costs: £1,174
Health effects
Mean change
VAS: - 4.4 (SE 0.31)
NDI: -10.6 (SE 0.79)
Recovery: 0.78 (SE 0.05)
QALY: 0.750 (SE 0.01)
Incremental costs:
-£349
Cost per unit of outcome
improved in:
BGA versus SMT
Recovery: £17,444
Pain: £388
NDI: £152
Cost per QALY gained:
£17444
Korthals-de Bos
2003 63,64
Netherlands a
Analysis: CUA, CEA
Statistical analysis:
Intention to Treat analysis,
CIs based on bootstrapping
(500 simulations), ICERs
based on bootstrapping
(5000 simulations)
Pain (VAS), disability
(NDI), perceived recovery,
EuroQoL EQ-5D
SMT (mobilisation)
Costs: £604
Health effects
Mean change
VAS: 4.2 (2.4)
NDI: 7.2 (7.5)
Recovery: 71.7 (43)
Utility: 0.820 (0.13)
PT
Costs: £1753
Health effects
Mean change
VAS: 3.1 (2.9)
NDI: 6.3 (8.0)
Recovery: 62.7 (37)
Utility: 0.790 (0.14)
GP care
Costs: £1864
Health effects
SMT (mobilisation) –
GP care
Incremental costs:
-£1260
PT – GP care
Incremental costs:
-£111
Cost per unit of outcome
improved in:
Dominance of SMT over
GP care and PT in terms of
recovery and pain
Cost per QALY gained:
Dominance of SMT over
GP care and PT in terms of
QALYs
Cost per unit of outcome
improved in:
PT over GP care
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Table 4. (continued)
Study ID Analysis Health Outcomes
Mean Costs
Mean (SD) Health Effects
Difference in Costs
Incremental Ratio
Mean change
VAS: 4.1 (2.9)
NDI: 8.5 (7.4)
Recovery: 56.3 (36)
Utility: 0.770 (0.16)
Pain
£111
NDI
£50
Cost per QALY gained:
Dominance of PT over GP
care in terms of QALYs
Lewis 2007 65,66
UK a
Analysis: CUA, CEA
Statistical analysis:
Intention to Treat analysis,
CIs for differences in means
using parametric methods,
CIs for uncertainty in cost
estimates were based on
bootstrapping (5000
simulations), linear
regression to adjust for
baseline covariates, multiple
imputation technique to
account for missing data
Disability (NPQ), EuroQoL
EQ-5D
SMT (MOB + MAN) +
A&E
Costs: £367
Health effects
NPQ: 10.2 (14.1)
QALY: 0.342 (0.114)
PSWD + A&E
(advice + exercise)
Costs: £410
Health effects
NPQ: 10.3 (15.0)
QALY: 0.360 (0.094)
A&E (advice + exercise)
Costs: £452
Health effects
NPQ: 11.5 (15.7)
QALY: 0.362 (0.114)
SMT (MOB + MAN) +
A&E - A&E (advice +
exercise)
Incremental costs:
-£84
PSWD + A&E
(advice+ exercise) -A&E
(advice + exercise)
Incremental costs:
-£42
Cost per unit of outcome
improved in NPQ:
A&E over SMT
£65
Cost per QALY gained:
A&E over SMT
£4672
Shoulder Pain
Bergman 2010 57–60
Netherlands b
Analysis: CEA
Statistical analysis: paired
sample t-test, bootstrapping
(2000 replications) to
compare mean costs
between the groups and
estimate 95% CIs, Intention
to Treat analysis
Perceived recovery (%),
shoulder pain, shoulder
disability, general health
SMT (MOB + MAN) +
GP care
Costs: £1443
Health effects
Recovery: 41%
Pain: 5.9 (5.4)
Disability: 33.0 (34.6)
General health: 0.11 (0.19)
GP care
Costs: £686
Health effects
Recovery: 35%
Pain: 5.2 (5.5)
Disability: 20.3 (35.9)
General health: 0.08 (0.21)
Incremental costs:
£757
Cost per unit of outcome
improved in:
Recovery: £151
Pain: £1081
Disability: £60
General health: £25222
Ankle Fracture
Lin 2008 67,68
Australia b
Analysis: CUA
Statistical analysis:
Intention to Treat analysis,
ANCOVA for group-
differences, imputation of
missing values, two sample
t-test and bootstrapping
(1000 replications) 95%
CIs for group-differences
in costs
Quality of life (AQoL),
activity limitation (LEFS)
MT + PT
Costs: £2267
Health effects: NR
PT
Costs: £1754
Health effects: NR
Incremental costs:
£513
Incremental effects:
between-group difference
AQoL: 1.3 (0.1, 2.5)
QALY: -0.09 (-0.6, 0.4)
Cost per QALY gained:
-£1075
AQoL, assessment of quality of life; BGA, behavioral graded activity; BPM, brief pain management; CEA, cost-effectiveness analysis; CI, confidence
interval; CUA, cost-utility analysis; EQ-5D, European Quality of Life-5 Dimensions; GP, general practitioner; HRQoL, health-related quality of life;
LEFS, lower extremity functional scale; MAN, manipulation; MOB, mobilization; MT, manual therapy; NDI, Neck Disability Score; NPQ, Northwick
Park Neck Pain Questionnaire; NR, not reported; ODI, Oswestry Disability Index; OSM, osteopathic manual therapy; PT, physiotherapy; QALY, quality-
adjusted life year; RMDQ, Roland-Morris Disability; SMT, spinal manual therapy; VAS, visual analogue scale.
a High risk of bias (≤ 5 items of the recommended criteria by the Cochrane
b Low risk of bias (≥ 6 items of the recommended criteria by the Cochrane Back Review Group were satisfied)
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but only at WTP thresholds of less than £100. For QALYs,
at £30000 per QALY gained threshold, the probabilities for
A&E alone, A&E plus manual therapy, and A&E plus
PSWD were 30%, 44%, and 26%, respectively.
Shoulder Pain. The trial by Bergman et al57–60 evaluated
spinal manual therapy plus usual GP care (relative to usual
GP care alone in patients with shoulder pain. At 6 months
of follow-up, the manual therapy group incurred nonsig-
nificantly higher total costs compared with the GP care
alone group (mean difference, £757). The mean improve-
ments in perceived recovery (5.0%), shoulder pain (0.7), and
general health (0.03) were in favor of the manual therapy
group, but the differences were not statistically signifi-
cant. The mean shoulder disability score was the only
outcome significantly favoring the manual therapy over
GP care (12.7). The ICERs for the manual therapy plus
GP care vs GP care alone for perceived recovery, pain,
disability, and general health were £151, £1081, £60, and
£25222, respectively.
Ankle Fracture. Lin et al67,68 compared manual therapy
added to physiotherapy with physiotherapy in patients with
ankle fractures. At 6 months of follow-up, themean between-
group differences in mean AQoL score (1.3, P = .04),
lower extremity function (−1.0, P = .70), and QALYs gained
(−0.09) were not statistically significant. Similarly, there was
no difference in total health care costs between the study
groups (£513).DISCUSSION
This review identified limited evidence indicating that
manual therapy techniques (eg, osteopathic spinal manipula-
tion, physiotherapy consisting of manipulation and mobiliza-
tion techniques, and chiropractic manipulation), in addition to
other treatments or alone, are more cost-effective than usual
GP care (alone or with exercise), spinal stabilization, GP
advice, advice to remain active, or brief pain management for
improving low back pain and/or disability. Similarly, one
study57 demonstrated that spinal manipulation in addition to
GP care was more cost-effective than GP care alone in
reducing shoulder pain and related disability. The extra costs
needed for 1-unit improvement in low back or shoulder pain/
disability score or 1 QALY gained were lower than the WTP
thresholds reported across the studies.
The cost-effectiveness of manual therapy for improving
neck pain, disability, and QALYs gained in comparison
with other treatments was not consistent across the studies.
For example, one trial63,64 demonstrated the domination of
chiropractic manipulation over physiotherapy or GP care in
improving neck pain and QALYs gained. In 2 other trials,
either alternative intervention (behavioral graded activity)
was more cost-effective than manual therapy45 or theprobability for manual therapy being more cost-effective
compared with advice plus exercise was too low.65
The evidence regarding cost-effectiveness of manual
therapy compared with physiotherapy for reducing pain and
disability related to ankle fractures, as reported in one study,67
has been insufficient and inconclusive because of small sample
size and uncertainty around the cost-effectiveness measure.
It is difficult to draw definitive conclusions regarding the
comparative cost-effectiveness of manual therapy techniques
in patients with spinal pain due to the paucity, clinical
heterogeneity (eg, different techniques, wide variety of
comparators), and study-related shortcomings (eg, small
sample, short follow-up, high uncertainty in the estimates of
ICERs) of the identified evidence. For example, the use of
different manual therapy techniques (eg, manipulation,
mobilization, and chiropractic care) in combination with
other interventions (eg, physiotherapy, exercise, and GP care)
leads to differential effectiveness profiles, thereby limiting the
comparability of results across studies. The nonspecific or
contextual effects (eg, intervention fidelity, placebo effect,
practitioner's experience) due to the complexity of interven-
tions and lack of patient blinding may have biased the study
results for subjective outcome measures such as pain,
disability, and QOL. Because none of the studies used a
sham/control arm, it is difficult to tease out the specific
effects of treatment from patients' differential expectation
(or practitioner's experience/skill set) across the study
treatment arms.70
All the included studies were trial-based economic
evaluations. None of the studies used economic modeling to
extrapolate beyond the trial data to look at the longer-term
cost-effectiveness of the different interventions. Studies
reporting cost-effectiveness acceptability curves (CEACs)
used bootstrapping, none of the studies used simple one-
way or multiway sensitivity analyses to check for
uncertainty in any of the key cost factors, which may be
driving the ICER.Limitations and Strengths
The findings of this review are not directly comparable
with those of other systematic reviews,28–33,71–81 given the
differences in scope, research question, study inclusion/
exclusion criteria, types of economic evaluation, and
interventions. The findings of these reviews were either
inconclusive because of the paucity and heterogeneity of
the evidence for manual therapy28–33 or showed some cost-
effectiveness of manual therapy over alternative treatments
(eg, usual care and exercise).71,75,76,78,79,81
The applicability of findings of the included studies,
despite them being pragmatic, may be limited to only
countries with similar health care system and considerations
of utility (eg, calculations based on the same QOL
instrument). The applicability may also be limited by the
Practical Applications
• There is some limited evidence indicating
that manual therapy techniques are more cost-
effective than usual GP care, spinal stabili-
zation, GP advice, advice to remain active, or
brief pain management for improving low
back and shoulder pain/disability.
• The extra costs needed for 1-unit improve-
ment in low back or shoulder pain/disability
score or 1 QALY gained were lower than the
WTP thresholds reported across the studies.
• The cost-effectiveness of manual therapy for
improving neck pain, disability, and QALYs
gained in comparison with other treatments
was not consistent across the studies.
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and short follow-ups of the studies.
The strengths of the current review include the
reviewer's use of systematic and independent strategies
to minimize the ROB in searching, identifying, selecting,
extracting, and appraising the primary studies. The search
strategy was applied to multiple electronic databases and
other sources such as references of relevant primary
studies and systematic reviews. Also, this review
summarized the evidence from studies that evaluated
costs and effectiveness simultaneously through cost-
effectiveness and/or CUAs by providing ICERs. As a
limitation, this review included only RCT-based cost-
effectiveness evaluations.
This paper provides a platform for further research
into the cost-effectiveness of manual therapy for the
management of musculoskeletal conditions. The findings
underscore the paucity of good-quality published
evidence on this issue. This is based on the small number
of identified RCTs focus of which is rather limited
(ie, nonspecific spinal pain). The insufficient evidence on
cost-effectiveness may be explained by difficulties in
obtaining cost data, lack of expertise in economic
outcomes, and/or perceived societal discomfort with
assigning monetary units to human health. 32 Raising
awareness among the chiropractic community about the
importance of undertaking more high quality economic
evaluations is needed.
Because several studies did not use QALYs as an
outcome measure, this presents difficulty for decision
makers if they wish to compare value for money across
musculoskeletal conditions with other health conditions
such as cancer and cardiovascular disease, in line with
the cost-effectiveness thresholds set by NICE. Consid-
eration of the competing demand/supply side issues of
manual therapy and how these issues may vary across
countries is needed. Furthermore, it is not clear whether
the affordability of manual therapy in countries where
the provision of such services fall outside publicly
funded arrangements is likely to influence utilization;
this raises questions about the generalizability of the
current reported findings.
We recommend that future studies report unit cost
calculation with costs broken down by each service to
allow the judgment as to whether all relevant costs for
a given perspective were considered and how the total
costs were calculated. If ethically justifiable, future
trials need to include sham or no treatment arm to
allow the assessment and separation of nonspecific
effects (eg, patient's expectation) from treatment effects.
More exploration is warranted about which characteris-
tics of manual therapy (eg, mode/frequency of adminis-
tration or choice of spinal regions) are important for
clinically relevant and patient-centered outcomes.
Finally, greater consideration is needed to improvereporting quality of primary studies evaluating
manual therapy.CONCLUSIONS
Preliminary evidence from this review shows some
economic advantage of manual therapy relative to other
interventions used for the management of musculoskeletal
conditions. However, at present, there is a paucity of
evidence on the cost-effectiveness and/or cost-utility
evaluations for manual therapy interventions. Further
improvements in the methodological conduct and report-
ing quality of economic evaluations of manual therapy are
warranted in order to facilitate adequate evidence-based
decisions among policy makers, health care practitioners,
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APPENDIX 1.
Medline via Ovid Searched on 25/08/2011.
1 Musculoskeletal Manipulations/ 647
2 Manipulation, Orthopedic/ 3196
3 Manipulation, Chiropractic/ 599
4 Manipulation, Spinal/ 947
5 Manipulation, Osteopathic/ 275
6 Chiropractic/ 2910
7 ((orthopaedic or orthopedic or chiropract$ or chirother$ or osteopath$ or spine or spinal or vertebra$ or craniocervical or craniosacral
or “cranio sacral” or cervical or lumbar or occiput or invertebral or thoracic or sacral or sacroilial or joint$) adj3 (manipulat$ or
adjustment$ or mobilis$ or mobiliz$ or traction$)).tw.
3748
8 ((manual or manipulat$ or mobilis$ or mobiliz$) adj (therap$ or intervention$ or treat$ or rehab$)).tw. 2087
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 10834
10 Osteopathic Medicine/ 2395
11 osteopath$.tw. 3382
12 chiropractic$.tw. 2684
13 chirother$.tw. 16
14 10 or 11 or 12 or 13 6949
15 9 or 14 14942
16 “friction massage$”.tw. 22
17 naprapath$.tw. 13
18 Rolfing.tw. 17
19 “myofascial release”.tw. 53
20 “Bowen technique”.tw. 5
21 “apophyseal glide$”.tw. 7
22 “bone setting”.tw. 47
23 bonesetting.tw. 14
24 “body work$”.tw. 103
25 “high-velocity low-amplitude”.tw. 94
26 HVLA.tw. 21
27 ((Maitland or Kaltenborn or Evejenth or Evjenth or Mulligan or McKenzie or Cyriax or Mills or Mennell or Stoddard) adj3
(manipulat$ or adjustment$ or mobilis$ or mobiliz$ or traction$)).tw.
17
28 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 386
29 15 or 28 15151
30 meta.ab. 37484
31 synthesis.ab. 356691
32 literature.ab. 333797
33 randomized.hw. 385278
34 published.ab. 229952
35 meta-analysis.pt. 30214
36 extraction.ab. 106463
37 trials.hw. 241415
38 controlled.hw. 476605
39 search.ab. 111279
40 medline.ab. 37563
41 selection.ab. 186391
42 sources.ab. 136598
43 trials.ab. 231023
44 review.ab. 521671
45 review.pt. 1668378
46 articles.ab. 43106
47 reviewed.ab. 273309
48 english.ab. 34846
49 language.ab. 55323
50 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 3593074
51 comment.pt. 449950
52 letter.pt. 723862
53 editorial.pt. 282269
54 Animals/ 4854330
55 Humans/ 12014638
56 54 and 55 1282233
57 54 not 56 3572097
(continued on next page)
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58 51 or 52 or 53 or 57 4613893
59 50 not 58 3118764
60 29 and 59 3786
61 meta-analysis.mp,pt. 47915
62 review.pt. 1668378
63 search$.tw. 167947
64 61 or 62 or 63 1800589
65 29 and 64 1754
66 60 or 65 3869
67 randomized controlled trial.pt. 314563
68 controlled clinical trial.pt. 83211
69 randomized.ab. 220397
70 placebo.ab. 127540
71 drug therapy.fs. 1488387
72 randomly.ab. 159149
73 trial.ab. 227916
74 groups.ab. 1056224
75 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 2752777
76 exp animals/not humans.sh. 3654092
77 75 not 76 2335094
78 29 and 77 2268
79 exp Cohort Studies/ 1124315
80 cohort$.tw. 181429
81 controlled clinical trial.pt. 83211
82 Epidemiologic Methods/ 27602
83 limit 82 to yr=“1971-1988” 9410
84 79 or 80 or 81 or 83 1268588
85 29 and 84 1737
86 66 or 78 or 85 5540
87 interview$.mp. 191377
88 experience$.mp. 552122
89 qualitative.tw. 86147
90 qualitative research/ 11344
91 87 or 88 or 89 or 90 772947
92 29 and 91 1194
93 86 or 92 6056
94 Economics/ 26136
95 exp “costs and cost analysis”/ 159102
96 economics, dental/ 1829
97 exp “economics, hospital”/ 17368
98 economics, medical/ 8493
99 economics, nursing/ 3851
100 economics, pharmaceutical/ 2258
101 (economic$ or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic$).ti,ab. 343421
102 (expenditure$ not energy).ti,ab. 14521
103 value for money.ti,ab. 654
104 budget$.ti,ab. 14687
105 94 or 95 or 96 or 97 or 98 or 99 or 100 or 101 or 102 or 103 or 104 457195
106 ((energy or oxygen) adj cost).ti,ab. 2340
107 (metabolic adj cost).ti,ab. 607
108 ((energy or oxygen) adj expenditure).ti,ab. 13432
109 106 or 107 or 108 15754
110 105 not 109 453621
111 letter.pt. 723862
112 editorial.pt. 282269
113 historical article.pt. 278980
114 111 or 112 or 113 1272089
115 110 not 114 428994
116 Animals/ 4854330
117 Humans/ 12014638
118 116 not (116 and 117) 3572097
119 115 not 118 404419
120 29 and 119 562
121 93 or 120 6232
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